Insulet (GOV) Financial Statements
Insulet Financial Overview
Insulet's market cap is currently $9.26B. The company's EPS TTM is $5.36; its P/E ratio is 27.93; Insulet is estimated to report earnings on November 4, 2026, and the estimated EPS forecast is $1.42. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.71B | $ 2.07B | $ 1.70B | $ 1.31B | $ 1.10B |
| Gross Profit | $ 1.94B | $ 1.45B | $ 1.16B | $ 805.60M | $ 752.10M |
| Operating Income | $ 473.80M | $ 308.90M | $ 220.00M | $ 37.60M | $ 126.00M |
| EBITDA | $ 509.60M | $ 423.70M | $ 323.60M | $ 109.00M | $ 139.60M |
| Net Income | $ 247.10M | $ 418.30M | $ 206.30M | $ 4.60M | $ 16.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 716.10M | $ 953.40M | $ 704.20M | $ 674.70M | $ 791.60M |
| Total Assets | $ 3.19B | $ 3.09B | $ 2.59B | $ 2.25B | $ 2.05B |
| Total Debt | $ 1.05B | $ 1.42B | $ 1.45B | $ 1.43B | $ 1.29B |
| Net Debt | $ 334.70M | $ 468.60M | $ 798.10M | $ 808.90M | $ 494.90M |
| Total Liabilities | $ 1.68B | $ 1.88B | $ 1.86B | $ 1.77B | $ 1.49B |
| Stockholders' Equity | $ 1.52B | $ 1.21B | $ 732.70M | $ 476.40M | $ 556.30M |
| Cash Flow | |||||
| Free Cash Flow | $ 377.70M | $ 305.40M | $ 70.10M | $ -38.30M | $ -190.80M |
| Operating Cash Flow | $ 569.30M | $ 430.30M | $ 145.70M | $ 119.00M | $ -68.10M |
| Investing Cash Flow | $ -222.70M | $ -146.20M | $ -119.40M | $ -191.10M | $ -82.70M |
| Financing Cash Flow | $ -595.30M | $ -28.10M | $ -13.60M | $ -40.30M | $ 40.70M |
Currency in USD